Viewing Study NCT03086993


Ignite Creation Date: 2025-12-25 @ 1:10 AM
Ignite Modification Date: 2026-02-21 @ 4:08 AM
Study NCT ID: NCT03086993
Status: UNKNOWN
Last Update Posted: 2022-03-24
First Post: 2017-03-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma
Sponsor: Delcath Systems Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bile Duct Cancer View
None Intrahepatic Cholangiocarcinoma View
Keywords: